Saltar al contenido
Merck

PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease.

BioEssays : news and reviews in molecular, cellular and developmental biology (2003-10-28)
Erik R Vossenaar, Albert J W Zendman, Walther J van Venrooij, Ger J M Pruijn
RESUMEN

Peptidylarginine deiminase (PAD, EC 3.5.3.15) enzymes catalyze the conversion of protein-bound arginine to citrulline. This post-translational modification may have a big impact on the structure and function of the target protein. In this review, we will discuss the effects of citrullination and its involvement in several human diseases, including rheumatoid arthritis and multiple sclerosis. So far, four isotypes of PAD have been described in mammals. We describe the existence of PAD in non-mammalian vertebrates and the existence of a fifth mammalian PAD. In addition, tissue-specific expression, genomic organization and evolutionary conservation of the different PAD isotypes will be discussed in detail. This article contains supplementary material which may be viewed at the BioEssays website at http://www.interscience.wiley.com/jpages/0265-9247/suppmat/2003/25/v25.1106.html.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
PAD6, GST tagged human, recombinant, expressed in baculovirus infected Sf9 cells, ≥70% (SDS-PAGE), buffered aqueous glycerol solution